Clinical Trial Update: Prophylactic PEG-rhG-CSF During cCRT in LA-NSCLC

View source ↗

Summary

The trial update reports completion of a study evaluating prophylactic PEG-rhG-CSF during concurrent chemoradiotherapy for locally advanced non-small cell lung …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• -iii Non-small Cell Lung Cancer

Drugs mentioned

• PEG-rhG-CSF (pegylated recombinant human granulocyte colony-stimulating factor)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Stage II-III Non-small Cell Lung Cancer, Concurrent Chemotherapy | Status: COMPLETED